Clinical Trial: A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06952465) titled 'A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis' on April 29.

Brief Summary: The purpose of this study is to further evaluate the safety of deucravacitinib treatment in Japanese patients with psoriasis in the real-world setting

Study Start Date: Jan. 24

Study Type: OBSERVATIONAL

Condition: Psoriasis

Intervention: DRUG: Deucravacitinib

As per product label

BIOLOGICAL: Any biologic treatment for psoriasis

According to the product label

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Bristol-Myers Squibb

Published by HT Digital Content ...